000 01651 a2200481 4500
005 20250513201854.0
264 0 _c20000211
008 200002s 0 0 eng d
022 _a1043-0342
024 7 _a10.1089/10430340050016166
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRogulski, K R
245 0 0 _aDouble suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization.
_h[electronic resource]
260 _bHuman gene therapy
_cJan 2000
300 _a67-76 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenoviridae
_xenzymology
650 0 4 _aAnimals
650 0 4 _aArtificial Gene Fusion
650 0 4 _aCell Survival
650 0 4 _aCombined Modality Therapy
650 0 4 _aCytosine Deaminase
650 0 4 _aFemale
650 0 4 _aGenetic Therapy
650 0 4 _aGenetic Vectors
650 0 4 _aHerpesvirus 1, Human
_xenzymology
650 0 4 _aInjections, Intralesional
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aNeoplasm Transplantation
650 0 4 _aNeoplasms, Experimental
_xradiotherapy
650 0 4 _aNucleoside Deaminases
_xgenetics
650 0 4 _aRadiation Tolerance
650 0 4 _aThymidine Kinase
_xgenetics
650 0 4 _aVirus Replication
700 1 _aWing, M S
700 1 _aPaielli, D L
700 1 _aGilbert, J D
700 1 _aKim, J H
700 1 _aFreytag, S O
773 0 _tHuman gene therapy
_gvol. 11
_gno. 1
_gp. 67-76
856 4 0 _uhttps://doi.org/10.1089/10430340050016166
_zAvailable from publisher's website
999 _c10601867
_d10601867